What is the catalog number for Balstilimab (PDCD1/PD1/CD279) - Research Grade Biosimilar?

The catalog number for Balstilimab (PDCD1/PD1/CD279) - Research Grade Biosimilar is 10-947.

What sizes are available for Balstilimab (PDCD1/PD1/CD279) - Research Grade Biosimilar?

Balstilimab (PDCD1/PD1/CD279) - Research Grade Biosimilar is available in the following size(s): 0.1 mg.

Balstilimab (PDCD1/PD1/CD279) - Research Grade Biosimilar

Product Specifications

Background

PD-1 monoclonal antibody balstilimab is used to treat cervical cancer, balstilimab monotherapy and anti-CTLA-4 monoclonal antibody zalifrelimab combined with balstilimab for metastatic cervical cancer.

Immunogen

Homo sapiens / PDCD1/PD1/CD279 [Homo sapiens]

Clonality

Recombinant Monoclonal

Conjugation

Unconjugated

Type

Primary Antibodies, Biosimilars

Source

CHO cells

Field of Research

Cancer, Immunology

Purification

>95%

Concentration

Batch dependent

Buffer

PBS buffer pH7.5

Modification

None

Shipping Conditions

Blue Ice

Storage Conditions

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.